Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 17, 2024

BUY
$0.3 - $0.46 $163 - $250
545 Added 218.0%
795 $0
Q4 2023

Mar 04, 2024

BUY
$0.38 - $0.65 $94 - $161
248 Added 12400.0%
250 $612,000
Q4 2023

Feb 16, 2024

BUY
$0.38 - $0.65 $0 - $1
2 New
2 $226,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.65B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Vima LLC Portfolio

Follow Vima LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vima LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vima LLC with notifications on news.